Skip to content

Hemogenyx Pharmaceuticals PLC Sustainability Reports

Hemogenyx Pharmaceuticals PLC is a clinical-stage biotechnology company developing novel therapies and treatments for blood diseases and cancers. Its focus includes the discovery and development of cell therapies, such as CAR-T treatments, and immunotherapies to improve bone marrow transplantation.

Sector: Professional & technical services

Country: United Kingdom

Exchange: London Stock Exchange

ISIN: GB00BQVXM815

8 reports from 2017 to 2025